Skip links

After a new cancer drug is approved for adults, pediatric clinical research takes an average of 9.5 more years.
After a new cancer drug is approved for adults, pediatric clinical research takes an average of 9.5 more years.

WHAT IF

we focused as much effort on solving cancer for children as we do on solving cancer for adults?

How we are advancing our mission

 

The Creating Hope Act

CREATING HOPE ACT PEDIATRIC PRV

WHAT IF there were drugs specially developed for children with life threatening illnesses?
MORE »

 

The Kids Act/RACE for Children Act

RACE FOR CHILDREN ACT

WHAT IF drugs developed for adults with cancer were also developed for kids?
MORE »

 

Compassionate Use Navigator

COMPASSIONATE USE NAVIGATOR

WHAT IF we could save a child by helping obtain an investigational drug?
MORE »

 

Tissue Donation

TISSUE DONATION

WHAT IF we could help pediatric cancer investigators get the tissue they need to succeed in their research?
MORE »

 

News

Extension of Creating Hope Act Pediatric PRV

Since 2012, the Creating Hope Act pediatric priority review voucher program (pediatric PRV or Creating Hope Act) has created almost $1 billion in R&D incentives for pediatric cancer and pediatric life threatening disease drugs. Today, we are proud to announce that the Senate Appropriations Committee released a short-term continuing appropriations measure to maintain government operations  read more

News

Congress Tackles #1 Disease Killer of Children

RACE for Children Act will give children with cancer access to the most promising treatments. This might sound like just a small, first step, but it actually reflects a level of buy-in and support that makes it an important milestone toward passage. read more

KVC Launches the Compassionate Use Navigator

Kids v Cancer is proud to announce the launch of the Compassionate Use Navigator, a new service for the pediatric oncology community that provides assistance to physicians and families and serves as a clearinghouse of up-to-date information on the compassionate use application process. Compassionate use, also called expanded access, is a process that allows patients  read more

What you can do today

Write Congress

Ask Congress to support the RACE for Children Act and the Creating Hope Act Pediatric PRV.
We make it easy. Write here»

Get Involved

Get in touch with us. Ask us a question.
Make a donation.
Join our Youth Board.

Donate

Please make your donation today. Your support makes our work possible. Thank you!

Recognition of our work

We have created almost $1 billion in R&D incentives for pediatric rare disease drug development.